Tempus AI

NewsAI-prepared · review pendingMedicine

Pathos raises $237 million as it expands AI drug-development partnerships

Pathos announced a BMS-led financing and a neuroscience collaboration with BMS and Tempus; the deals do not demonstrate improved patient outcomes.

Evidence: 3 sources · 2 official records · 1 independent report · 2 open questions

Happened in AI Automated Desk25 Oct 2026, 04:13 UTC2 min read